Europe’s pharma firms demand stronger IP protection

Adrian LadburyJanuary 13, 2022
Pill with European flag wrapped around it and blue balls inside, 3d illustration
Credit: Shutterstock/Fabio Berti

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called upon the EU to significantly strengthen provisions in free-trade agreements (FTAs) to strengthen intellectual property (IP) protection for European firms.

The federation said wordings in agreements need to be...

Want to read this article?

Register for ultimate access to this article and ALL our premium content

ULTIMATE ACCESS PROVIDES YOU WITH

  • Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
  • Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
  • Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
  • European and global surveys, rankings and special reports
  • National European local language newsletters
  • Preferential access to webinars and virtual and physical conferences

If you are already a registered user or subscriber you can LOGIN below for ultimate access:

Adrian LadburyJanuary 13, 2022
Back to top button